Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/16/08 → 12/15/12 |
Funding
- Merck and Company Inc: $20,882.00
A Phase III, Randomized, Open-Label, Parallel-Group, Dose Ranging Clinical Trial to Study the Safety and Efficacy of MK-0954/Losartan Potassium in Pediatric Patients with Hypertension
- Cottrill, Carol (PI)
- Coleman, Lisa (CoI)
- Kiessling, Stefan (CoI)
- Powers, Holly (CoI)